Altratech has developed and patented a fundamentally novel process to detect and quantify DNA, RNA, Antibody, and Antigen molecular targets. The process replaces the need for time consuming ‘biological amplification’ required for optical read-outs, with almost instant ‘electronic signal amplification’ and a digital read-out. This will enable a new generation of portable diagnostic products that have the simplicity of lateral flow tests and the performance of a laboratory PCR test.
This novel digital diagnostic technology enables robust, straightforward and flexible molecular diagnostics in any environment.
About Altratech
Altratech is a team of twenty scientists and engineers, including nine PhDs, from cross-functional backgrounds of molecular biology, organic and synthetic chemistry, microfluidics, engineering and CMOS semiconductor technologies. With over 200 years of combined experience, our vision is to create portable high-performance diagnostics which will enable the next generation of decentralised connected healthcare and wellbeing.
At Altratech, our mission is to enable next generation molecular detection.
This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.
Assay animation
In the News
Altratech awarded up to €10.5M by EIC Accelerator
1 Oct 2024: Altratech awarded up to €10.5M grant+equity support by EIC Accelerator: .... EIC Accelerator 2024 full awardee list.... (Altratech's submission preparation assisted by MyEUConsulting SPRL).
Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
Originally published on 360DX.com by Greg Cima, Mar23, 2023. By Greg Cima NEW YORK – Backed by a mix of governmental contracts and VC funding, Irish startup Altratech is laying out a bold vision that its home-use microfluidic tests could Read More
Meet us at our Tri-Con San Diego booth 305 on Mar 6-8, and hear CEO Tara Dalton present our technology at the home-diagnostics session
Hear from our CEO Tara Dalton as she presents our technology in the home diagnostics session on Tuesday 7th of March.Title of session: 'At-Home Next-Generation Molecular Detection with All-Synthetic PNA and CMOS'
